Traws Pharma
TRAW
TRAW
9 hedge funds and large institutions have $3.53M invested in Traws Pharma in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $4.36M → $3.53M (-$828K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
9
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$134K | |
| 2 | +$101K | |
| 3 | +$17K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8K |
Top Sellers
| 1 | -$421K | |
| 2 | -$92K | |
| 3 | -$38K | |
| 4 |
Renaissance Technologies
New York
|
-$17.3K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$8.83K |